Some new products featured include the generic version of Macrobid and eye drop accessories
FDA Approves Ranibizumab Injection for Diabetic Macular Edema
The therapy is now the first and only FDA-approved treatment that maintains vision with fewer treatments compared to standard-of-care injections.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Approves Spravato as Monotherapy for Major Depressive Disorder
The approval makes Johnson and Johnson’s esketamine nasal spray the first and only monotherapy for the treatment of major depressive disorder in adult patients.
FDA Clears DASH SARS-CoV-2, Flu A/B Combination Test
Using the DASH Rapid PCR System, providers can yield test results in under 1 minute of hands-on time.
FDA Approves Tirzepatide for Obstructive Sleep Apnea in Patients with Obesity
Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.
FDA Updates Veozah Label With Boxed Warning for Rare But Serious Liver Injury
The patient’s symptoms gradually resolved after discontinuing fezolinetant therapy.
